Metabolomic and network analysis of pharmacotherapies for sensorineural hearing loss

Otology and Neurotology

Volumn 35, Issue 1, 2014, Pages 1-6

  Muurling, Tjeerd ^a,b   Stankovic, Konstantina M ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ERK1 2; Ingenuity pathway analysis; Metabolomic analysis; Networkmedicine; Sensorineural hearing loss; Tretinoin

Indexed keywords

CYCLOSPORIN; DEXAMETHASONE; RETINOIC ACID;

ARTICLE; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; METABOLOMICS; PERCEPTION DEAFNESS; SIGNAL TRANSDUCTION;

CYCLOSPORINE; DEXAMETHASONE; HEARING LOSS, SENSORINEURAL; HUMANS; METABOLOMICS; SIGNAL TRANSDUCTION; TRETINOIN;

EID: 84891758905     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0000000000000254     Document Type: Article

References (29)

1. Nance WE. The genetics of deafness. Ment Retard Dev Dis Res Rev 2003;9:109-19
2. Morton CC, Nance WE. Newborn hearing screeningYa silent revolution. N Engl J Med 2006;354:2151-64
3. World Health Organisation. Deafness and Hearing Impairment. Available at: Ghttp://www.who.int/mediacentre/factsheets/fs300/en/ index.html9. Accessed February 22, 2013
4. American Speech-Language-Hearing Association. The Prevalence and Incidence of Hearing Loss in Adults. Available at: Ghttp:// www.asha.org/public/ hearing/disorders/prevalence-adults.htm9 . Accessed February 22, 2013
5. Hereditary Hearing Loss Homepage. Up-to-date overview of the genetics of hereditary hearing impairment. Available at: Ghttp:// hereditaryhearingloss.org/ 9. Accessed February 22, 2013
6. Stamatiou GA, Stankovic KM. A comprehensive network and pathway analysis of human deafness genes. Otol Neurotol 2013;34: 961-70
7. Ingenuity Systems. Available at: Gwww.ingenuity.com9 and http://pages.ingenuity.com/rs/ingenuity/images/wp-ingenuity- metabolomics.pdf [IPAref]. Accessed September 14, 2012
8. Goodacre R. MetabolomicsVthe way forward. Metabolomics 2005;1:1-2
9. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabási AL. The largescale organization of metabolic networks. Nature 2000;407:651-4
10. Barabási AL, Gulbahce N, Loscalzo J. Network medicine: A networkbased approach to human disease. Nat Rev Genet 2011;12:56-68
11. Pawson T, Linding R. Network medicine. FEBS Lett. 2008;582: 1266-70
12. Schrattenholz A, Groebe K, Soskic V. Systems biology approaches and tools for analysis of interactomes and multi-target drugs. Methods Mol Biol 2010;662:29-58
13. Pujol A, Mosca R, Farrés J, Aloy P. Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci. 2010;31:115-23
14. Valencia-Cruz AI, Uribe-Figueroa LI, Galindo-Murillo R, et al. Whole genome gene expression analysis reveals casiopei'na-induced apoptosis pathways. PLoS One 2013;8:e54664
15. Durga J, Verhoef P, Anteunis LJ, Schouten E, Kok FJ. Effects of folic acid supplementation on hearing in older adults: A randomized, controlled trial. Ann Intern Med. 2007;146:1-9
16. Jeong H, Mason SP, Barabási AL, Oltvai ZN. Lethality and centrality in protein networks. Nature 2001;411:41-2
17. Ohno M, Ikenaka Y, Ishizuka M. All-trans retinoic acid inhibits the recruitment of ARNT to DNA, resulting in the decrease of CYP1A1 mRNA expression in HepG2 cells. Biochem Biophys Res Commun 2012;417:484-9
18. Battaglia A, Pak K, Brors D, Bodmer D, Frangos JA, Ryan AF. Involvement of ras activation in toxic hair cell damage of the mammalian cochlea. Neuroscience 2003;122:1025-35
19. Lahne M, Gale JE. Damaged-induced activation of ERK 1/2 in cochlear supporting cells is a hair cell death-promoting signal that depends on extracellular ATP and calcium. J Neurosci 2008;28: 918-28
20. Kohno M, Tanimura S, Ozaki K. Targeting the extracellular signalregulated kinase pathway in cancer therapy. Biol Pharm Bull 2011; 34:1781-4
21. Fennema O. Fennema's Food Chemistry. Boca Raton, FL: CRC Press Taylor & Francis Group, 2008:454-5
22. Frenz DA, Liu W, Cvekl A, et al. Retinoid signaling in inner ear development: A ''Goldilocks'' phenomenon. Am J Med Genet 2010; 152A:2947-61
23. Mingaud F, Mormede C, Etchamendy N, et al. Retinoid hyposignaling contributes to aging-related decline in hippocampal function in short-term/working memory organization and long-term declarative memory encoding in mice. J Neurosci 2008;28:279-91
24. Karabulut H, Karadag AS, Acar B, et al. The effect of oral isotretinoin (13-cis retinoic acid) on hearing systems in patients with acne vulgaris: A prospective study. Int J Dermatol 2011;50: 1139-43
25. Maeda Y, Fukushima K, Hirai M, Kariya S, Smith RJ, Nishizaki K. Microarray analysis of the effect of dexamethasone on murine cochlear explants. Acta Otolaryngol 2010;130:1329-34
26. Liu L, Walker EA, Kissane S, et al. Gene expression and miR profiles of human corneal fibroblasts in response to dexamethasone. Invest Ophthalmol Vis Sci 2011;52:7282-8
27. Lee MJ, Gong DW, Burkey BF, Fried SK. Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: A microarray study. Am J Physiol Endocrinol Metab 2011; 300:E571-80
28. Scheiber J, Chen B, Milik M, et al. Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis. J Chem Inf Model 2009;49:308-17
29. Chang RL, Xie L, Xie L, Bourne PE, Palsson BK. Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS Comput Biol 2010;6:e1000938